3D genome organization shapes DNA damage susceptibility to platinum-based drugs

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Platinum (Pt) drugs are crucial in cancer chemotherapy, with known cytotoxic effects and resistance mechanisms.
• However, factors influencing DNA's susceptibility to Pt drug-induced damage within the cell nucleus remain unclear.

Purpose of the Study:

• To investigate the role of nuclear chromatin location in Pt drug-induced DNA damage susceptibility.
• To understand how 3D genome organization affects DNA damage patterns and chemoresistance.

Main Methods:

• Integration of damage-seq experimental data with 3D genome structure information.
• Analysis of DNA damage susceptibility in relation to nuclear chromatin positioning and nuclear bodies.
• 3D structure mapping of DNA damage in cisplatin-resistant versus sensitive cells.

Main Results:

• Nuclear chromatin location significantly impacts Pt drug-induced DNA damage susceptibility in vivo.
• Cisplatin DNA damage susceptibility patterns correlate with chromatin positions relative to nuclear bodies and compartments.
• Oxaliplatin-induced DNA damage distribution differs in resistant versus sensitive cells, with increased damage in peripheral gene-poor chromatin and decreased damage in nuclear speckles.

Conclusions:

• Nuclear chromatin organization is a key determinant of DNA damage susceptibility to platinum-based chemotherapy.
• Chemoresistance development involves a strategic redistribution of nuclear DNA damage.
• Understanding these spatial dynamics can inform future cancer treatment strategies.